Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
24
self-reported 11–50 band
Founded
2019
7 years
Legal entities
1
ABR
Office countries
1
1 address
Funding rounds
None on record
Company type
Privately Held
self-reported
Legal entity
1 brand → 1 confirmed entity
IMMVIRX PTY LTD
ABN86634890761
Legal entities
Show as table · ImmVirX: 1 registry entity
| IMMVIRX PTY LTD | ABN 86634890761 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
ImmVirX is an Australian company founded in 2019 with a mission to improve outcomes for patients with cancer types in which immunotherapy treatments have limited effect. The company is developing a bio-selected RNA virus to induce tumour inflammation and achieve immune cell infiltration via the RIG-I pathway. The targets for this approach are Ovarian, Head & Neck and those indications which present with liver metastases such as Colorectal, Hepatocellular carcinoma and Pancreatic cancer. The approach includes combination therapy with Immune Checkpoint Inhibitors and CAR-T agents using bio-selected RNA virus.
The company founders, Malcolm McColl and Prof. Darren Shafren, were Managing Director and CSO of Viralytics, an ASX listed oncolytic virus company acquired in June 2018 by Merck and Co. Inc. for A$502 million. The ImmVirX team includes key management and researchers from Viralytics and is based at the former Viralytics laboratory facilities in Newcastle Australia.
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
Addresses
- AUHMRI Building, 2 Kookaburra Circuit; New Lambton Heights, NSW 2305Primary
Grid intelligence Members
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
FAQ
Which legal entity operates under ImmVirX?
One New South Wales entity on the ABR: IMMVIRX PTY LTD (ABN 86 634 890 761), high confidence.
How many people work at ImmVirX?
24 counted staff profiles at January 2026, inside the self-reported 11–50 band.
Where does ImmVirX have offices?
One address on record, Australia only. Primary: HMRI Building, 2 Kookaburra Circuit, New Lambton Heights, NSW 2305.
Has ImmVirX raised funding?
None linked to this brand.
What does ImmVirX list as its specialties?
Four tags on the brand's own list, among them biotech and oncology.
Which companies are listed alongside ImmVirX?
Four peer profiles on record: AusBiotech and Novatrials.